References
- Davenport H. W. Salicylate damage to the gastric mucosal barrier. N Engl J Med 1967; 276: 1307–12
- Berkowitz J. M., Adler S. N., Sharp J. T., Warner C. W. Reduction of aspirin induced gastroduodenal mucosal damage with ranitidine. J Clin Gastroenterol 1986; 8: 377–80
- Kimmey M. G., Silverstein F. E., Saunders D. R., Chapman R. C. Reduction of endoscopically assessed acute aspirin induced gastric mucosal injury with cimetidine. Dig Dis Sci 1987; 32: 851–6
- Stalnikowicz R., Pollak D., Eliakim A., et al. Cimetidine decreases indomethacin induced duodenal mucosal damage in patients with acute musculoskeletal disorders. Gut 1988; 29: 1578–82
- Stalnikowicz R., Pollak D., Eliakim A., et al. Indomethacin induced gastroduodenal damage is not affected by cotreatment with ranitidine. J Clin Gastroenterol 1989; 11: 178–82
- Abakken L., Larsen S., Osnes M. Cimetidine tablets or suspension for the prevention of gastrointestinal mucosal lesion caused by non-steroidal anti-inflammatory drugs. Scand J Gastroenterol 1989; 18: 369–75
- Robinson M. G., Griffin J. W., Bowers J., et al. Effect of ranitidine on gastroduodenal mucosal damage induced by non-steroidal anti-inflammatory drugs. Dig Dis Sci 1989; 34: 424–8
- Ehsanullah R. S B, Page M. C., Tildesley G., Wood J. R. Prevention of gastroduodenal damage induced by non-steroidal antiinflammatory drugs: controlled trial of ranitidine. Br Med J 1988; 297: 1017–20
- Burgett D. W., Chiverton S. G., Hunt R. H. Is there an optimal degree of acid suppression for healing of duodenal ulcers. Gastroenterology 1990; 97: 345–51
- Oddsson E., Gudjonsson H., Thjodleifsson B. Endoscopic findings in the stomach and duodenum after treatment with enteric coated and plain naproxen tablets. Scand J Gastroenterol 1990; 25: 231–3
- Lanza F., Peace K., Gustitus L., Rack M. F., Dickson B. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration. Am J Gastroenterol 1988; 83: 143–6
- Szabo S., Spill W. F., Rainsford K. D. Non-steroidal anti-inflammatory drug-induced gastropathy. Mechanisms and management. Med Toxicol Adverse Drug Exp 1989; 4: 77–94
- Graham D. Y., Smith J. L., Spjut H. J., Torres E. Gastric adaption. Gastroenterology 1988; 95: 327–33
- Shorock C. J., Rees D. W. Adaption to NSAID induced gastric mucosal damage; role of local PGE2 metabolism. Gut 1989; 30: A723
- Lanza F. L., Fakouhi D., Rubin A., et al. A double blind placebo controlled comparison of the efficacy and safety of 50, 100 and 200 micrograms of misoprostol QID in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms. Am J Gastroentrol 1989; 84: 633–6
- Jeranek G. C., Kimmey M. B., Saunders D. R., et al. Misoprostol reduces gastroduodenal injury from one week of aspirin; an endoscopic study. Gastroenterology 1989; 96(2 Pt Suppl)650–61
- Aadland E., Fausa O., Vatn M., et al. Protection by misoprosol against naproxen induced gastric mucosal damage. Gastroenterology 1988; 95: 289–94
- Graham D. Y., Agrawal N. M., Roth S. H. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double blind, placebo-controlled trial. Lancet 1988; 2: 1277–80
- Lanza F. L., Aspinal R. L., Swabb E. A., et al. Double blind placebo-controlled endoscopic comparison of the mucosal protective effects of cytotec versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. Gastroenterology 1988; 95: 289–95